chr16-83912348-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 4P and 7B. PM2PM5BP4_ModerateBP6BS1
The NM_012213.3(MLYCD):c.929G>A(p.Arg310Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000125 in 1,614,164 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R310P) has been classified as Likely pathogenic.
Frequency
Consequence
NM_012213.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MLYCD | NM_012213.3 | c.929G>A | p.Arg310Gln | missense_variant | 4/5 | ENST00000262430.6 | NP_036345.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MLYCD | ENST00000262430.6 | c.929G>A | p.Arg310Gln | missense_variant | 4/5 | 1 | NM_012213.3 | ENSP00000262430.4 |
Frequencies
GnomAD3 genomes AF: 0.000447 AC: 68AN: 152164Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000100 AC: 25AN: 249494Hom.: 0 AF XY: 0.0000739 AC XY: 10AN XY: 135384
GnomAD4 exome AF: 0.0000848 AC: 124AN: 1461882Hom.: 0 Cov.: 31 AF XY: 0.0000784 AC XY: 57AN XY: 727240
GnomAD4 genome AF: 0.000512 AC: 78AN: 152282Hom.: 1 Cov.: 32 AF XY: 0.000497 AC XY: 37AN XY: 74462
ClinVar
Submissions by phenotype
Deficiency of malonyl-CoA decarboxylase Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 09, 2022 | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Jan 31, 2023 | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at